News About: Pharm. Industry


Korea's pharmaceutical exports to Japan grew 11.7 percent in 2003

Korean exports for pharmaceuticals to Japan increased 11.7 percent to $128 million last year, following a surging growth rate of 39.1 percent from a year earlier, according to data released by the Korea Pharmaceutical...

Novartis discloses 16 oncology projects

Novartis AG held its first Asia-Pacific Oncology Summit in Hainan, China, on February 22 and said that a total of 16 oncology projects are being undertaken to provide a brad range of innovative therapies. In that ...

Domestic pharmaceutical firms to speed up global expansion

A number of local pharmaceutical companies have established their off-shore affiliates as part of intensive efforts to increase their global presence and overcome the protracted business slump in the domestic pharmace...

AstraZeneca Korea names new managing director

AstraZeneca Korea said that it has elected Lee Young-joon as its new managing director in charge of cardiovascular and circulatory fields. He will sit on the post from March 2. Lee has had various executive posts a...

2004 pharmaceutical export targeted at U$950,500 thousands.

President Chung Seung-whan of the Korea Pharmaceutical Trade Association announced in the 48th general congress at Textile House Hall at 10 a.m. on Feb. 25 that the 2004 pharmac...

CJ to introduce intradermal BCGvaccine SSI in Korea

CJ Corporation, a local maker of Capacin inj. (capreomycin) for treatment of tuberculosis infections, saidit has recently entered into an agreement with Denmark-based StatensSerumInstitute (SSI) for the exclusive dist...

SMEDDS based Hepaphil boasts of better bioavailability

KMS Company said that it has marketed Hepaphil soft capsule (biphenyl dimethyl dicarboxylate; BDD) to improve the dissolution rate of poorly water soluble drug using self-microe...

US FDA approves Alimtaas first-line regimen for mesothelioma

Eli Lilly and Company said recently that the US Food and Drug Administration approved Alimta (pemetrexed), a first-line therapy developed by Eli Lilly designed to treat people with pleural mesothelioma. The FDA allows...

Edward Keller to launch CRO business in Korea.

Edward Keller, a Korea branch of the multinational commercial company named Diethelm Keller Siber Hegner, started a CRO business in Korea. The company has mainly engaged in the ...

Listed drug companies to achieve stable and profitable management.

Amid a sustained general economy recession the pharmaceutical industries have stressed their business strategies into a more stable and profitable management direction. All listed drug companies having a fiscal ye...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.